Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-11 · 1878 (6) · 188990
DOI: 10.1016/j.bbcan.2023.188990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-11. Verfasst von Sona Ciernikova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: sona.ciernikova@savba.…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 157 Literaturangaben. Gefördert von: Slovenská Akadémia Vied, Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky, Vedecká Grantová Agentúra MŠVVaŠ SR a SAV.
Abstract (Originalsprache)
Treatment resistance, together with acute and late adverse effects, represents critical issues in the management of cancer patients. Promising results from preclinical and clinical research underline the emerging trend of a microbiome-based approach in oncology. Favorable bacterial species and higher gut diversity are associated with increased treatment efficacy, mainly in chemo- and immunotherapy. On the other hand, alterations in the composition and activity of gut microbial communities are linked to intestinal dysbiosis and contribute to high treatment-induced toxicity. In this Review, we provide an overview of studies concerning gut microbiota modulation in patients with solid and hematologic malignancies with a focus on probiotics, prebiotics, postbiotics, and fecal microbiota transplantation. Targeting the gut microbiome might bring clinical benefits and improve patient outcomes. However, a deeper understanding of mechanisms and large clinical trials concerning microbiome and immunological profiling is warranted to identify safe and effective ways to incorporate microbiota-based interventions in routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: sona.ciernikova@savba.sk.
- Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, Bratislava, Slovakia.
- Department of Oncohematology, Comenius University and National Cancer Institute, Bratislava, Slovakia.
- 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.
Förderung
- Slovenská Akadémia Vied
- Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
Zitieren
APA
Ciernikova, S., Sevcikova, A., Drgona, L., & Mego, M. (2023). Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(6), 188990. https://doi.org/10.1016/j.bbcan.2023.188990
Vancouver
Ciernikova S, Sevcikova A, Drgona L, Mego M. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(6):188990. doi:10.1016/j.bbcan.2023.188990
BibTeX
@article{Ciernikova2023,
author = {Ciernikova, Sona and Sevcikova, Aneta and Drgona, Lubos and Mego, Michal},
title = {Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {6},
pages = {188990},
doi = {10.1016/j.bbcan.2023.188990}
}
EUVIMED